Evolution of Resistance Against CRISPR/Cas9 Gene Drive

被引:184
|
作者
Unckless, Robert L. [1 ]
Clark, Andrew G. [2 ,3 ]
Messer, Philipp W. [3 ]
机构
[1] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[2] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA
[3] Cornell Univ, Dept Biol Stat & Computat Biol, 102J Weill Hall, Ithaca, NY 14853 USA
基金
美国国家卫生研究院;
关键词
CRISPR/Cas9; gene drive; homing drive; mutagenic chain reaction; whole population replacement; MUTAGENIC CHAIN-REACTION; SOFT SELECTIVE SWEEPS; DROSOPHILA-MELANOGASTER; NATURAL-POPULATIONS; PEST-MANAGEMENT; ADAPTATION; FIXATION; MUTATION; VECTOR; SYSTEM;
D O I
10.1534/genetics.116.197285
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
CRISPR/Cas9 gene drive (CGD) promises to be a highly adaptable approach for spreading genetically engineered alleles throughout a species, even if those alleles impair reproductive success. CGD has been shown to be effective in laboratory crosses of insects, yet it remains unclear to what extent potential resistance mechanisms will affect the dynamics of this process in large natural populations. Here we develop a comprehensive population genetic framework for modeling CGD dynamics, which incorporates potential resistance mechanisms as well as random genetic drift. Using this framework, we calculate the probability that resistance against CGD evolves from standing genetic variation, de novo mutation of wild-type alleles, or cleavage repair by nonhomologous end joining (NHEJ)-a likely by-product of CGD itself. We show that resistance to standard CGD approaches should evolve almost inevitably in most natural populations, unless repair of CGD-induced cleavage via NHEJ can be effectively suppressed, or resistance costs are on par with those of the driver. The key factor determining the probability that resistance evolves is the overall rate at which resistance alleles arise at the population level by mutation or NHEJ. By contrast, the conversion efficiency of the driver, its fitness cost, and its introduction frequency have only minor impact. Our results shed light on strategies that could facilitate the engineering of drivers with lower resistance potential, and motivate the possibility to embrace resistance as a possible mechanism for controlling a CGD approach. This study highlights the need for careful modeling of the population dynamics of CGD prior to the actual release of a driver construct into the wild.
引用
收藏
页码:827 / 841
页数:15
相关论文
共 50 条
  • [1] CRISPR/Cas9 Gene Drive: Growing Pains for a New Technology
    Reed, Floyd A.
    GENETICS, 2017, 205 (03) : 1037 - 1039
  • [2] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [3] CRISPR/Cas9 gene drives in genetically variable and nonrandomly mating wild populations
    Drury, Douglas W.
    Dapper, Amy L.
    Siniard, Dylan J.
    Zentner, Gabriel E.
    Wade, Michael J.
    SCIENCE ADVANCES, 2017, 3 (05):
  • [4] CRISPR/Cas9: The new era of gene therapy
    Alotaibi, Amal
    INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2020, 7 (10): : 20 - 29
  • [5] CRISPR/Cas9: the Jedi against the dark empire of diseases
    Khan, Sehrish
    Mahmood, Muhammad Shahid
    Rahman, Sajjad Ur
    Zafar, Hassan
    Habibullah, Sultan
    Khan, Zulqarnain
    Ahmad, Aftab
    JOURNAL OF BIOMEDICAL SCIENCE, 2018, 25
  • [6] CRISPR/Cas9 for overcoming drug resistance in solid tumors
    Saber, Ali
    Liu, Bin
    Ebrahimi, Pirooz
    Haisma, Hidde J.
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 28 (01) : 295 - 304
  • [7] CRISPR/Cas9
    杨丽
    中南医学科学杂志, 2016, 44 (05) : 585 - 585
  • [8] CRISPR/Cas9
    Mizuno, Naoaki
    Mizutani, Eiji
    Sato, Hideyuki
    Kasai, Mariko
    Nakauchi, Hiromitsu
    Yamaguchi, Tomoyuki
    BIO-PROTOCOL, 2019, 9 (13):
  • [9] Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9
    Li, Minghui
    Yang, Huihui
    Zhao, Jiue
    Fang, Lingling
    Shi, Hongjuan
    Li, Mengru
    Sun, Yunlv
    Zhang, Xianbo
    Jiang, Dongneng
    Zhou, Linyan
    Wang, Deshou
    GENETICS, 2014, 197 (02) : 591 - U219
  • [10] CRISPR/Cas9 gene drive technology to control transmission of vector-borne parasitic infections
    Nateghi Rostami, Mahmoud
    PARASITE IMMUNOLOGY, 2020, 42 (09)